HAZARDOUS AGENT INJECTION SYSTEM
Injection systems comprising a powered injector and one or more hazardous agents are disclosed.
1 - 21 . (canceled)
22 . A prefilled syringe, comprising a container including a pharmaceutical solution formulation of a medicament with a concentration between about 5 mg/ml and about 25 mg/ml in a pharmaceutically acceptable solvent.
23 . The prefilled syringe according to claim 22 , including a dosage of between about 2.5 mg and about 5 mg of medicament.
24 . The prefilled syringe according to claim 22 , including between about 0.02 ml to about 4.0 ml of medicament.
25 . The prefilled syringe according to claim 24 , including less than about 3 ml of medicament.
26 . The prefilled syringe according to claim 24 , including about 4 ml of medicament.
27 . The prefilled syringe according to any of claim 22 through 26 , wherein the medicament is methotrexate.
28 . The prefilled syringe according to any of claim 22 through 26 , wherein the medicament is a hazardous agent.
29 . The prefilled syringe according to any of claim 22 through 26 , wherein the pharmaceutically acceptable solvent is selected from water or ethanol.
30 . The prefilled syringe according to any of claim 22 through 26 for subcutaneous administration.
31 . The prefilled syringe according to any of claim 22 through 26 , including between about 0.02 ml to about 4.0 ml of the pharmaceutical solution formulation.
32 . A prefilled syringe, comprising a container including a pharmaceutical solution formulation of between about 0.02 ml to about 4.0 ml of a medicament in a pharmaceutically acceptable solvent.
33 . The prefilled syringe according to claim 32 , including less than about 3 ml of medicament.
34 . The prefilled syringe according to claim 32 , including about 4 ml of medicament.
35 . The prefilled syringe according to claim 32 , wherein the pharmaceutical solution formulation includes a concentration of between about 5 mg/ml and about 25 mg/ml of the medicament.
36 . The prefilled syringe according to claim 35 , including a dosage of between about 2.5 mg and about 5 mg of medicament.
37 . The prefilled syringe according to any of claim 32 through 36 , wherein the medicament is methotrexate.
38 . The prefilled syringe according to any of claim 32 through 34 , wherein the medicament is testosterone.
39 . The prefilled syringe according to any of claim 32 through 36 , wherein the medicament is a hazardous agent.
40 . The prefilled syringe according to any of claim 32 through 36 , wherein the pharmaceutically acceptable solvent is selected from water or ethanol.
41 . The prefilled syringe according to any of claim 32 through 36 for subcutaneous administration.
42 . The prefilled syringe according to any of claim 32 through 36 , including between about 0.02 ml to about 4.0 ml of the pharmaceutical solution formulation.